We have recently received a number of queries from women and healthcare professionals about increased screening intervals for immunocompromised patients, especially those on immunosuppressant medication for inflammatory conditions. In the absence of HPV, there is no evidence that these women are at additional risk. The current QA standards still recommend that women pre and post organ transplantation, those on renal dialysis and women living with HIV have annual screening.